Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Jeanie MaloneDepartment of Integrative Oncology, British Columbia Cancer Research Institute, 675 W 10th Avenue, Vancouver, BC V5Z 1L3, Canada.ORCID 0000-0003-1739-642X
Adrian S TanskanenDepartment of Integrative Oncology, British Columbia Cancer Research Institute, 675 W 10th Avenue, Vancouver, BC V5Z 1L3, Canada.
Chloe HillDepartment of Integrative Oncology, British Columbia Cancer Research Institute, 675 W 10th Avenue, Vancouver, BC V5Z 1L3, Canada.ORCID 0009-0006-0497-1033
Allan Zuckermann CynamonDepartment of Integrative Oncology, British Columbia Cancer Research Institute, 675 W 10th Avenue, Vancouver, BC V5Z 1L3, Canada.
Lien HoangDepartment of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, 910 West 10 Avenue, Vancouver, BC V5Z 1M9, Canada.
Calum MacAulayDepartment of Integrative Oncology, British Columbia Cancer Research Institute, 675 W 10th Avenue, Vancouver, BC V5Z 1L3, Canada.
Jessica N McAlpineDepartment Obstetrics and Gynaecology, Division Gynecologic Oncology, University of British Columbia and BC Cancer, 2775 Laurel St, 6th Floor, Vancouver, BC V5Z 1M9, Canada.ORCID 0000-0001-6003-485X
Pierre M LaneDepartment of Integrative Oncology, British Columbia Cancer Research Institute, 675 W 10th Avenue, Vancouver, BC V5Z 1L3, Canada.ORCID 0000-0002-6370-4182
Funding
Canadian Institutes of Health Research (CIHR) FRN 153154
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
autofluorescence imagingcancer morphologyendoscopic imagingfalloposcopyoptical biopsyoptical coherence tomographyovarian cancer
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Multimodal Optical Imaging of Ex Vivo Fallopian Tubes to Distinguish Early and Occult Tubo-Ovarian Cancers. · full record | OpenQuestion